Viewing nowMegapolmin 500 mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200402630 · Notified 2004.03.18 · Insurance code 643500850
Treatment of type 2 diabetes mellitus
This medication is used for patients with Type 2 diabetes whose blood sugar control is insufficient with diet and exercise alone, especially in overweight adults. It can also be used alone or in combination with other oral hypoglycemic agents or insulin in adult patients. It helps control blood sugar in children over 10 years of age and adolescents during growth when used alone or in combination with insulin. This drug effectively supports blood glucose management and plays an important role in the treatment of diabetes.
The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control, this medicine must be started at a low dose. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When the dose is up to 2000mg, it is usually administered in 2 divided doses, in the morning and evening. For doses above 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. At the start of treatment and during dose adjustment, measure fasting blood glucose to assess response to treatment and determine the minimum effective dose. Measure blood glycated hemoglobin concentrations approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin concentrations to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in a patient whose glucose was previously controlled by diet alone, short-term treatment with this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡), provided they do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg, administered in 2~3 divided doses.
This medication can cause severe lactic acidosis or hypoglycemia, and extreme caution is required. It should not be used in patients with moderate to severe renal dysfunction, dehydration, severe infections, acute myocardial infarction, etc. In patients with acute heart failure or before and after diagnostic tests using iodine-based contrast agents, the administration of this drug should be stopped, and only resumed after renal function is confirmed to be normal. It should not be used in patients with hypersensitivity to this drug or in those with Type 1 diabetes, metabolic acidosis, etc. In cases of severe infection, major trauma, or before and after surgery, discontinuation of the medication is necessary temporarily, and it should be resumed after the patient’s condition is recovered. Patients with poor nutritional status or impaired liver function and those consuming excessive alcohol should use this medication with caution. During the treatment, irregular meals, vigorous exercise, and taking other interacting drugs may pose a risk for lactic acidosis and hypoglycemia, so careful management is required. Lactic acidosis is a rare but serious side effect; if symptoms such as fatigue, muscle pain, difficulty breathing, or abdominal pain occur, promptly inform healthcare personnel. Gastrointestinal disturbances are common but usually temporary, and symptoms may be reduced by taking the medication with meals or gradually increasing the dosage. This medication is excreted through the kidneys, so regular renal function tests should be conducted before and during treatment; the medication should be discontinued if renal function declines. Alcohol can increase the risk of side effects, so excessive drinking should be avoided during treatment. During pregnancy, the potential effects on the fetus must be carefully considered, and it is not to be used if there is a risk of placental dysfunction or preeclampsia. During breastfeeding, as this medication is secreted in breast milk, it is advised to consult a physician about the appropriate measures, whether to discontinue breastfeeding or the medication. Elderly patients may have a risk of declining renal function, so dosage adjustments and frequent checks of renal function are necessary. Caution is needed when taking it with other hypoglycemic agents or specific medications, as interactions may alter blood sugar control efficacy. In case of overdose, blood dialysis can remove the medication, so contact healthcare personnel immediately and receive appropriate treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is essential to maintain a storage temperature between 1 degree and 30 degrees Celsius room temperature. This will safely preserve the drug's effectiveness.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.